Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer.

Kuribayashi K, Matsunaga T, Sakai T, Wada Y, Tateno K, Murase K, Fujimi A, Takimoto R, Terui T, Kato J, Sasaki A, Satoh M, Niitsu Y. A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer. Intern Med. 2005 May; 44(5):490-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.